Outpace Bio

Discovery Tools (Healthcare) · Seattle, WA · Founded 2020 · Privately Held (backing)

Developer of cell therapies designed to improve the safety and efficacy of gene therapies. Outpace Bio is based in Seattle, WA and was founded in 2020. Its last known valuation is $220 million. It has raised $199 million across 1 recorded round; the latest was a $144 million Series B in Jul 2024.

Last price · $/share
—
Implied valuation
$220.0M
Total raised
$199.0M
Last round
Early Stage VC (Series B)
Jul 2024
No prints on record

No secondary trades in Outpace Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Outpace Bio with a free account
  • ·The complete investor list: 20 names
  • ·Watch Outpace Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Outpace Bio prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Outpace Bio stock.